Karin Helena Johansson Wingstrand
Director/Board Member at XBRANE BIOPHARMA AB
Profile
Karin Helena Johansson Wingstrand is currently the Director at T-Bolaget AB since 2001, Independent Director at Xbrane Biopharma AB since 2015, Director at Sahlgrenska Forskningsstiftelsen, Director at Winkon Holding AB, Independent Director at Integrum AB since 2019, Director at Histolab Products AB, and Partner at Aqilion AB since 2014.
Previously, she was the Director at Adenovir Pharma AB from 2015 to 2018, Director at Xintela AB from 2014 to 2022, Director at Swecure AB from 2014 to 2018, and Global Head-Clinical Development at AstraZeneca AB from 1999 to 2008.
She holds a graduate degree from the University of Uppsala.
Karin Helena Johansson Wingstrand active positions
| Companies | Position | Start |
|---|---|---|
| XBRANE BIOPHARMA AB | Director/Board Member | 2014-12-31 |
| INTEGRUM AB | Director/Board Member | 2018-12-31 |
T-Bolaget AB
 T-Bolaget AB Financial ConglomeratesFinance T-Bolaget AB engages in investment and trading of securities, for a limited and closed group of owners. The company was founded on December 15, 1958 and is headquartered in Gothenburg, Sweden. | Director/Board Member | 2000-12-31 |
| Sahlgrenska Forskningsstiftelsen | Director/Board Member | - |
| Winkon Holding AB | Director/Board Member | - |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Private Equity Investor | 2014-02-12 |
| Histolab Products AB | Director/Board Member | - |
Former positions of Karin Helena Johansson Wingstrand
| Companies | Position | End |
|---|---|---|
| XINTELA AB | Director/Board Member | 2021-12-31 |
| Swecure AB | Director/Board Member | 2017-12-31 |
| ░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░ | ░░░░░░░░ | - |
Training of Karin Helena Johansson Wingstrand
| University of Uppsala | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| XBRANE BIOPHARMA AB | Health Technology |
| XINTELA AB | Health Technology |
| INTEGRUM AB | Health Technology |
| Private companies | 9 |
|---|---|
T-Bolaget AB
T-Bolaget AB Financial ConglomeratesFinance T-Bolaget AB engages in investment and trading of securities, for a limited and closed group of owners. The company was founded on December 15, 1958 and is headquartered in Gothenburg, Sweden. | Finance |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Finance |
| Sahlgrenska Forskningsstiftelsen | |
| Swecure AB | Health Technology |
Mevia AB
 Mevia AB Other Consumer ServicesConsumer Services Mevia AB provides drug package that helps patients manage their drug intake. It also provides intelligent solutions for medical treatments. The firm’s solutions address the greatest challenge in medical treatments improving adherence. The company also manages by increasing the patient support and providing personal adherence feedback in real time. Mevia works closely with their clients to develop innovative packaging and IT solutions that provide patients with the best possible experience. The company was founded by Linnea Olsson and Jesper Hassel and is headquartered in Gothenburg, Sweden. | Consumer Services |
| Winkon Holding AB | |
| Histolab Products AB | |
Adenovir Pharma AB
 Adenovir Pharma AB Pharmaceuticals: MajorHealth Technology Adenovir Pharma AB provides solutions for the treatment of eye diseases. The firm offers treatments and business development opportunities to the pharmaceutical industry. It manufactures antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). The company was founded by Per Niklas Arnberg on December 11, 2007 and is headquartered in Helsingborg, Sweden. | Health Technology |
- Stock Market
- Insiders
- Karin Helena Johansson Wingstrand
